Table 2: Effect of treatment on mortality and recovery at day 6 and 12.
|
Event of interest |
Time of follow-up |
Unadjusted Hazard Ratio [95%CI] |
p-value |
Adjusted Hazard Ratio* [95%CI] |
p-value |
|
Mortality |
Day-12 |
0.47 [0.25-0.86] |
0.016 |
0.56 [0.27-1.19] |
0.136 |
|
Day-6 |
0.42 [0.22-0.81] |
0.009 |
0.60 [0.27-1.32] |
0.208 |
|
|
Recovery** |
Day-12 |
1.08 [0.67-1.74] |
0.725 |
0.97 [0.58-1.61] |
0.908 |
|
Day-6 |
1.54 [0.17-13.83] |
0.698 |
1.23 [0.09-16.91] |
0.874 |
*Adjusted for age, sex, time from symptoms onset to admission, hypertension and oxygen saturation at admission
**Models with competing risk